Pharming Group to participate in September investor conferences
Pharming Group (Euronext Amsterdam: PHARM/Nasdaq: PHAR) has announced its participation in two major investor conferences in September 2024. The company will be present at the 2024 Wells Fargo Healthcare Conference in Boston from September 4-6, where CEO Sijmen de Vries will engage in a fireside chat on September 6 at 08:45 AM ET. Additionally, Pharming will attend the H.C. Wainwright 26th Annual Global Investment Conference in New York from September 9-11, with de Vries presenting on September 9 at 10:30 AM ET.
Both presentations will be available via live webcast and replay on Pharming's website. Investors interested in one-to-one meetings with Pharming's management team can contact the company's Investor Relations team or their Wells Fargo or H.C. Wainwright representatives.
Pharming Group (Euronext Amsterdam: PHARM/Nasdaq: PHAR) ha annunciato la sua partecipazione a due importanti conferenze per investitori a settembre 2024. L'azienda sarà presente al 2024 Wells Fargo Healthcare Conference a Boston dal 4 al 6 settembre, dove il CEO Sijmen de Vries parteciperà a una chiacchierata informale il 6 settembre alle 08:45 ET. Inoltre, Pharming parteciperà al H.C. Wainwright 26th Annual Global Investment Conference a New York dal 9 all'11 settembre, con de Vries che presenterà il 9 settembre alle 10:30 ET.
Entrambe le presentazioni saranno disponibili tramite webcast live e replay sul sito web di Pharming. Gli investitori interessati a incontri one-to-one con il team di gestione di Pharming possono contattare il team delle Relazioni con gli Investitori dell'azienda o i loro rappresentanti di Wells Fargo o H.C. Wainwright.
Pharming Group (Euronext Ámsterdam: PHARM/Nasdaq: PHAR) ha anunciado su participación en dos importantes conferencias de inversionistas en septiembre de 2024. La empresa estará presente en la Conferencia de Salud Wells Fargo 2024 en Boston del 4 al 6 de septiembre, donde el CEO Sijmen de Vries participará en una charla informal el 6 de septiembre a las 08:45 AM ET. Además, Pharming asistirá a la 26ª Conferencia Anual Global de Inversión H.C. Wainwright en Nueva York del 9 al 11 de septiembre, con de Vries presentando el 9 de septiembre a las 10:30 AM ET.
Ambas presentaciones estarán disponibles a través de una transmisión en vivo y repetición en el sitio web de Pharming. Los inversionistas interesados en reuniones uno a uno con el equipo de gestión de Pharming pueden ponerse en contacto con el equipo de Relaciones con Inversores de la empresa o con sus representantes de Wells Fargo o H.C. Wainwright.
Pharming Group (Euronext 암스테르담: PHARM/Nasdaq: PHAR)은 2024년 9월 두 개의 주요 투자자 회의에 참여한다고 발표했습니다. 회사는 9월 4일부터 6일까지 보스턴에서 열리는 2024 웰스 파고 건강 관리 회의에 참석하며, CEO Sijmen de Vries는 9월 6일 오전 08:45 ET에 비공식 대담에 참여할 예정입니다. 또한 Pharming은 9월 9일부터 11일까지 뉴욕에서 열리는 H.C. Wainwright 제26회 연례 글로벌 투자 회의에도 참석하며, de Vries는 9월 9일 오전 10:30 ET에 발표할 예정입니다.
두 발표 모두 Pharming의 웹사이트를 통해 생중계 및 재방송됩니다. Pharming 경영진과 일대일 회의를 원하는 투자자는 회사의 투자자 관계팀 또는 웰스 파고 또는 H.C. Wainwright의 대표에게 연락할 수 있습니다.
Pharming Group (Euronext Amsterdam: PHARM/Nasdaq: PHAR) a annoncé sa participation à deux grandes conférences pour investisseurs en septembre 2024. L'entreprise sera présente à la 2024 Wells Fargo Healthcare Conference à Boston du 4 au 6 septembre, où le PDG Sijmen de Vries participera à une discussion informelle le 6 septembre à 08h45 ET. De plus, Pharming assistera à la 26e Conférence Annuelle Mondiale sur l'Investissement H.C. Wainwright à New York du 9 au 11 septembre, avec de Vries qui présentera le 9 septembre à 10h30 ET.
Les deux présentations seront disponibles en direct via webcast et replay sur le site internet de Pharming. Les investisseurs intéressés par des réunions individuelles avec l'équipe de direction de Pharming peuvent contacter l'équipe des Relations Investisseurs de l'entreprise ou leurs représentants de Wells Fargo ou H.C. Wainwright.
Pharming Group (Euronext Amsterdam: PHARM/Nasdaq: PHAR) hat die Teilnahme an zwei wichtigen Anlegerkonferenzen im September 2024 angekündigt. Das Unternehmen wird vom 4. bis 6. September auf der 2024 Wells Fargo Healthcare Conference in Boston vertreten sein, wo CEO Sijmen de Vries am 6. September um 08:45 Uhr ET an einem informellen Gespräch teilnehmen wird. Darüber hinaus wird Pharming vom 9. bis 11. September an der H.C. Wainwright 26th Annual Global Investment Conference in New York teilnehmen, wobei de Vries am 9. September um 10:30 Uhr ET präsentierend wird.
Beide Präsentationen werden live über das Webcast sowie wiederholt auf der Website von Pharming verfügbar sein. Investoren, die an persönlichen Treffen mit dem Management-Team von Pharming interessiert sind, können sich an das Investor-Relations-Team des Unternehmens oder an ihre Vertreter von Wells Fargo oder H.C. Wainwright wenden.
- None.
- None.
Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the U.S. in the month of September:
- 2024 Wells Fargo Healthcare Conference, Boston, September 4-6
Sijmen de Vries, Chief Executive Officer, will participate in a fireside chat question and answer session on Friday, September 6 at 08:45 AM ET/14:45 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website. - H.C. Wainwright 26th Annual Global Investment Conference, New York, September 9-11
Sijmen de Vries, Chief Executive Officer, will present on Monday, September 9 at 10:30 AM ET/16:30 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.
For more information about these conferences, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Wells Fargo or H.C. Wainwright representative.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com
FTI Consulting, London, United Kingdom
Victoria Foster Mitchell/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Attachment
FAQ
Which investor conferences will Pharming Group (PHARM) attend in September 2024?
When and where will Pharming Group's CEO present at the Wells Fargo Healthcare Conference?
What time is Pharming Group's presentation at the H.C. Wainwright Global Investment Conference?
How can investors access Pharming Group's (PHARM) conference presentations?
How can investors schedule meetings with Pharming Group's management at these conferences?
